| 000 | 01665 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518033817.0 | ||
| 264 | 0 | _c20200601 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/s41375-019-0470-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMishra, Ameet K | |
| 245 | 0 | 0 |
_aMetformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells. _h[electronic resource] |
| 260 |
_bLeukemia _c11 2019 |
||
| 300 |
_a2695-2709 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aBortezomib _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 |
_aMultiple Myeloma _xmetabolism |
| 650 | 0 | 4 |
_aPhenformin _xpharmacology |
| 650 | 0 | 4 |
_aPlasma Cells _xpathology |
| 650 | 0 | 4 |
_aReceptors, Interleukin-6 _xmetabolism |
| 650 | 0 | 4 | _aSequence Analysis, RNA |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSyndecan-1 _xmetabolism |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 700 | 1 | _aDingli, David | |
| 773 | 0 |
_tLeukemia _gvol. 33 _gno. 11 _gp. 2695-2709 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41375-019-0470-4 _zAvailable from publisher's website |
| 999 |
_c29591949 _d29591949 |
||